Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-102391
Filing Date
2025-08-05
Accepted
2025-08-05 07:10:20
Documents
62
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q bold-20250630.htm   iXBRL 10-Q 2030337
2 EX-31.1 bold-ex31_1.htm EX-31.1 16623
3 EX-31.2 bold-ex31_2.htm EX-31.2 16901
4 EX-32.1 bold-ex32_1.htm EX-32.1 15925
  Complete submission text file 0000950170-25-102391.txt   7686009

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT bold-20250630.xsd EX-101.SCH 900382
65 EXTRACTED XBRL INSTANCE DOCUMENT bold-20250630_htm.xml XML 1484164
Mailing Address 10955 ALEXANDRIA WAY SUITE 100 SAN DIEGO CA 92121
Business Address 10955 ALEXANDRIA WAY SUITE 100 SAN DIEGO CA 92121 (858) 766-9912
Boundless Bio, Inc. (Filer) CIK: 0001782303 (see all company filings)

EIN.: 830751369 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41989 | Film No.: 251182770
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)